The change of ghrelin levels in intestinal parasitic infections

Journal of Medical Biochemistry

Volumn 29, Issue 1, 2010, Pages 34-38

  Erensoy, Ahmet ^a   Aydin, Suleyman ^a   Kelestimur, Neslihan ^a   Kirbag, Sevda ^a   Kuk, Salih ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Active inactive ghrelin; Aktivni neaktivni grelin; Arilesteraza; Arylesterase; Paraoksonaza; Paraoxonase; Parasite; Paraziti; Serum

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CHOLESTEROL; GHRELIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACYLATION AND DEACYLATION; ARTICLE; BLASTOCYSTIS HOMINIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENTAMOEBA; ENTAMOEBA COLI; ENTAMOEBA HISTOLYTICA; ENTEROBIUS VERMICULARIS; FECES; FEMALE; GIARDIA LAMBLIA; HUMAN; HYMENOLEPIS NANA; INTESTINE INFECTION; MALE; NONHUMAN; PARASITOSIS; RADIOIMMUNOASSAY; SPECTROPHOTOMETRY; TAENIA SAGINATA;

VERMES;

EID: 77749298289     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-010-0004-0     Document Type: Article

References (30)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kan gawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.
2. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and desacyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000; 279: 909-13.
3. Hosoda H, Kojima M, Mizushima T, Shimizu S, Kangawa K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 2003; 278: 64-70.
4. Carlini V P, Monzon ME, Varas MM, Cragnolini AB, Schiöth HB, Scimonelli TN, et al. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun 2002; 299: 739-43.
5. Fujino K, Inui A, Asakawa A, Kihara N, Fuji mura M, Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 2003; 550: 227-40.
6. Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2001; 2: 551-60.
7. Kojima M, Kangawa K. Ghrelin, an orexigenic signaling molecule from the gastrointestinal tract. Curr Opin Pharmacol 2002; 2: 665-8.
8. Nagaya N, Kangawa K. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr Opin Pharmacol 2003; 3: 146-51.
9. Yoshimoto A, Mori K, Sugawara A, Mukoyama M, Yahata K, Suganami T, et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002; 13: 2748-52.
10. Kumru S, Aydin S, Gursu M F, Ozcan Z. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women. Eur J Obstet Gynecol Reprod Biol 2004; 114: 177-81.
11. Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, et al. Paraoxonase-2 is a ubi-quitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 2001; 276: 44444-9.
12. Mackness B, Durrington PN, Mackness MI. Human serum paraoxonase. Gen Pharmacol 1998; 31: 329-36.
13. WHO. The evidence is in: deworming helps meet the Millennium Development Goals. 2005; WHO/CDS/CPE/PVC/2005.12.
14. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger E P, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-30.
15. Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126-38.
16. Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhi-bition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clim Biochem 1992; 30: 391-5.
17. Horoz M, Aslan M, Selek S, Koylu AO, Bolukbas C, Bolukbas F F, et al. PON1 status in haemodialysis patients and the impact of hepatitis C infection. Clin Biochem 2007; 40: 609-14.
18. Toshinai K, Mondal MS, Nakazato M, Date Y, Murakami N, Kojima M, et al. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administra tion. Biochem Bio phys Res Commun 2001; 281: 1220-5.
19. Ashraf A, Mick G, Meleth S, Wang X, McCormick K. Insulin treatment reduces pre-prandial plasma ghrelin concentrations in children with type 1 diabetes. Med Sci Monit 2007; 13: CR533-7.
20. De Vriese C, Hacquebard M, Gregoire F, Carpentier Y, Delporte C. Ghrelin interacts with human plasma lipoproteins. Endocrinology 2007; 148: 2355-62.
21. Kiliç E, Yazar S, Saraymen R. Lipid Peroxidation Level in Patients with Blastocystosis. Inönü Üniversitesi Tip Fakültesi Dergisi 2003; 10: 1-3.
22. Adelekan DA, Thurnham DI, Adekile AD. Reduced anti-oxidant capacity in paediatric patients with homozygous sickle cell disease. Eur J Clin Nutr 1989; 43: 609-14.
23. Kiliç E, Yazar S, Saraymen R, Özbilge H. Serum Lipid Peroxidation Level in Patients with Taeniasis saginata. Türkiye Parazitoloji Dergisi 2004; 2: 91-3.
24. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996; 33: 498-507.
25. Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129-35.
26. Nevin DN, Zambon A, Seidel SL, Motulsky AG. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am J Hum Genet 1988; 43: 230-8.
27. Hong SH, Song J, Min WK, Kim JQ. Genetic variations of the paraoxonase gene in patients with coronary artery disease. Clin Biochem 2001; 34: 475-81.
28. Marsillach J, Camps J, Ferré N, Beltran R, Rull A, Mackness B, et al. Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease. BMC Gastroenterol 2009; 14: 9: 3.
29. Aydin S, Guzel S P, Kumru S, Aydin S, Akin O, Kavak E, et al. Serum leptin and ghrelin concentrations of maternal serum, arterial and venous cord blood in healthy and preeclamptic pregnant women. J Physiol Biochem 2008; 64: 51-9.
30. Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, et al. Correlation of plasma oxidized low-density lipo protein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 2004; 53: 297-302.